Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous PRP intratesticular injection for non-obstructive azoospermia after failed mdTESE
IRCT20250731066710N1Phase 2Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Aug 2025
- Modality
- Adoptive Cell Transfer → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of autologous platelet-rich plasma in nonobstructive azoospermia (NOA), sponsored by Mashhad University of Medical Sciences. Primary endpoint: Presence of sperm and evaluation of spermatogenesis status after PRP injection. Started Aug 2025; status: completed.
02
Drugs
autologous platelet-rich plasma
03
Conditions
nonobstructive azoospermia (NOA)
Beyond the preview
Go deeper on IRCT20250731066710N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250731066710N1.